TMF, what you just argued is that STSI is getting even less revenue per bottle than longs had hoped. I'm not sure how that is a good thing, but yes if it were $40 instead of $60... then we'd be looking at closer to 21,000 users. Still not very impressive.
But this accounting angle is trivial. I've completely debunked that in detail without any rebuttal from those who initially promoted it...
So hopefully we can put that misinformation to rest.
Sure doctors can prescribe anything... but there is a reason they often promote drugs before supplements... generally speaking. There is a reason Dr Oz is not talking about Anatabine as well. It is not sufficiently proven. Still years away from anything conclusive. They aren't going to risk their reputations on something that is being used by less than 20,000 people regularly and something that has only a few narrow studies promoted by the manufacturer.
In this age of lawsuits, doctors simply aren't going to take risks promoting an unknown unless they feel safe in doing so.
News 
Market Data 
Discover 
